Browse Items (2 total)

Tags: 2005, Age Factors Australia Child Child, Australia and New Zealand of the 79 medicines granted paediatric exclusivity in the USA, Backlog, British Journal of Clinical Pharmacology, by age grouping, Drug Licensure, Grieve J, Journal Article, legislation & jurisprudence, Newborn Legislation, Norris P, number of patients likely to be treated with each drug in a year, PedPal Lit, Preschool Drug Approval/legislation & jurisprudence Great Britain Humans Infant Infant, regarding: usefulness in patients with the condition, Reith D, Standards, statistics & numerical data New Zealand Pediatrics, statistics & numerical data Pharmaceutical Preparations, supply & distribution United States%X AIMS: To determine the paediatric licensing status in the USA, the Electronic Medicines Compendium (UK), Tordoff J, UK

Tags: 2005, Administration, and those both licensed for paediatric use and subsidized increased from 356 (23.1%) to 441 (23.2%). The number of medicines with formulations suitable for paediatric use increased from 861 (55.7%) to 967 (50.8%), Backlog, British Journal of Clinical Pharmacology, but not for children under the age of two years., Chui J, ei ght (9%) for 2-11 years and 12 (13%) for 12-18 years. An additional 14 orally available chemical entities previously only licensed for adults, Journal Article, licensed medicines available in Australia in the calendar years 1998 and 2002 were examined. RESULTS: The total number of medicines licensed in Australia increased from 1544 to 1903, Newborn Licensure, Oral Adolescent Age Factors Australia Chemistry, PedPal Lit, Pharmaceutical Child Child, Preschool Dosage Forms Drug Approval/statistics & numerical data Humans Infant Infant, Reith D, statistics & numerical data, the number of licensed paediatric items increased from 579 (37.5%) to 725 (38.1%), Tordoff J, trends Pediatrics, trends Pharmaceutical Preparations, were licensed for children by 2002. CONCLUSIONS: There have been some improvements in medicines licensing for older children